No dose adjustment is required for patients with renal or hepatic impairment, though monitoring is advised if significant gastrointestinal adverse effects occur
Nicolay JP, Schneider J, Niemoeller OM, Artunc F, Portero-Otin M, Haik G Jr., et al
Clostridium beijerinckii: This novel Pendulum-exclusive strain produces the short-chain fatty acid butyrate, which helps the body process sugars and nourish the lining of the gut
Liu C, Teng ZQ, Santistevan NJ, Szulwach KE, Guo W, Jin P, et al
Halminen J, Sattaer N, Rawshani A et al (2022) Range of risk factor levels, risk control, and temporal trends for nephropathy and end-stage kidney disease in patients with type 1 and type 2 diabetes
doi:10.1016/0196-9781(86)90148-8 Kato N, Honda Y, Ebihara S, Naruse H, Takahashi Y